Skip to main content
Equibles

Candriam S.C.A.

Position in MLTX — MoonLake Immunotherapeutics

CIK 1537014 STRASSEN, N4
Back to MLTX Full portfolio

Position in MLTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$14,987,344
-$262,524 QoQ
Shares Held
769,766
-5.9% QoQ
Ownership
0.904%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#20
of 172 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MLTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. MLTX ranks #45 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 195,674 $122,010,565
2 RVMD
Revolution Medicines, Inc.
 556,392 $104,201,093
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 199,505 $99,100,118
4 ALNY
Alnylam Pharmaceuticals, Inc.
 314,512 $94,677,547
5 ONC
BeOne Medicines Ltd.
 289,735 $82,565,782
6 COGT
Cogent Biosciences, Inc.
 2,088,369 $80,819,880
7 ARGX
Argenx SE
 80,120 $74,332,932
8 ROIV
Roivant Sciences Ltd.
 1,990,510 $70,444,148

All Filings in MLTX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,987,344 769,766
2026-03-31 $15,249,868 818,126
2025-12-31 $1,770,456 134,329
2025-09-30 $958,213 133,642
2025-06-30 $6,835,976 144,830
2025-03-31 $6,818,496 174,520
2024-12-31 $12,317,825 227,476
2024-09-30 $12,050,380 239,000
2024-06-30 $10,508,830 239,000
2024-03-31 $12,004,970 239,000
2023-12-31 $11,172,150 185,000